Jorge Conde

GP at @a16z investing in bio + health | Former biotech founder + operator (CEO, CFO, CSO, CPO) 🧬🧫🧪 | Made in Miami 🇺🇸 🇵🇪 🇨🇺

[Jorge Conde @JorgeCondeBio]

Announcing our newest @a16zBioHealth fund: $700M to back the best founders working to make better medicines and to make the practice of medicine better.

To cure disease, to care for our sick, to fix what’s broken is deeply ingrained; it is medicine’s highest aim.

“At @a16z, we believe that the best thing that a society can do for a person is to give them a chance. Give them a shot at a great life…” - @bhorowitz

@vintweeta @julesyoo @BenPortney @Bryan__Faust @zakdoric @JayRughani @daisydwolf @janerheetweets Michael Cialone, Eva Steinman

[a16z @a16z]

At Andreessen Horowitz, we just raised over $15B.

With these new funds including American Dynamism ($1.176B), Apps ($1.7B), Bio + Health ($700M), Infrastructure ($1.7B), Growth ($6.75B), and other venture strategies ($3B), we raised over 18% of all venture capital dollars allocated in the United States in 2025.

Why did we raise the money and how do we plan to invest it?

Read more from Ben Horowitz: https://t.co/kXHKqUd8eZ

[Jorge Conde @JorgeCondeBio]

Boltz + @TakedaPharma announce new partnership, following @boltz_bio announcements on new SOTA small molecule + protein design models, a new Boltz API & partnerships to make Boltz models natively accesible across platforms:
👇

[Gabriele Corso @GabriCorso]

Very excited to announce our new partnership with Takeda! Takeda has been one of the most extensive and sophisticated users of our open-source models, and those models have already made a meaningful impact across multiple discovery programs. This partnership builds on that foundation, giving Takeda’s teams access to our latest proprietary models, pipelines, and infrastructure to further advance their discovery work! 🚀

[Jorge Conde @JorgeCondeBio]

@ParkLover_JA @boltz_bio @phylo_bio @benchling @AnthropicAI Enjoy!

[Jorge Conde @JorgeCondeBio]

The new state-of-the-art in bio x AI from @boltz_bio:
• BoltzMol-1: small-molecule hit-discovery
• BoltzProt-1: protein design
• API: run Boltz models efficiently
• Partnerships including @phylo_bio @benchling @AnthropicAI
👇

[Gabriele Corso @GabriCorso]

Big news from Boltz - our biggest update yet! 🚀
Today we’re releasing two new state-of-the-art models for protein and small molecule design with extensive wet lab validation and a new API to run all of our models on scalable GPUs wherever you (or your agents) work! 🔥

[Jorge Conde @JorgeCondeBio]

@srikosuri Beautiful

[Jorge Conde @JorgeCondeBio]

@VilaLeila35352 His visit to Spain was remarkable

[Jorge Conde @JorgeCondeBio]

A journalist asks the Pope: “Do you support Real Madrid or Barcelona?”

"That's easy...the Pope is for all the teams, but Prevost [his birth name] is a Real Madrid fan."

Quite the endorsement, but we could’ve used some divine intervention this season…

[Jorge Conde @JorgeCondeBio]

@skupor @DanMarino Little 1980s Jorge is crying inconsolably

[Jorge Conde @JorgeCondeBio]

@antoniogm 😔

[Dyno Therapeutics, Inc. @Dyno_Tx]

Boston’s first ever @Techweek_ kicks off today and we’re proud to be a founding host!

This Thursday, catch Dyno CEO @ekelsic on a panel with @JorgeCondeBio of @a16z and Katherine Andersen of @HSBCInnovation to discuss how AI is delivering real impact in healthcare now, and what comes next.

For Dyno, that future is centered on giving patients everywhere the ability to improve their health by taking action at the genetic level through safe, effective, and accessible genetic medicines – that’s what our vision of #GeneticAgency is all about.

📍 Next in Care: How AI is Reshaping Healthcare
Hosted by HSBC Innovation Banking and a16z
Thursday, May 28 | 4–6 p.m. | Boston, MA

Learn more: https://t.co/yI3iucxDVX

[Jorge Conde @JorgeCondeBio]

@srikosuri @vintweeta @OctantBio @rhomsany 😂

[Jorge Conde @JorgeCondeBio]

@adamfeuerstein Should I ignore the critic reviews?

[Jorge Conde @JorgeCondeBio]

@PeterL4e Welcome home, hermano!!!

[Jorge Conde @JorgeCondeBio]

@ericvishria Wow what a fantastic milestone. Congratulations!

[Jake Wintermute 🧬/acc @SynBio1]

Doing biotech is so metal

[Jorge Conde @JorgeCondeBio]

@GrantHesser Such an amazing story

[Jorge Conde @JorgeCondeBio]

When “undruggable” meets “indefatigable” — the long, “impossible” journey from academia to industry that led to the discovery of KRAS and a potential breakthrough for pancreatic cancer patients.

https://t.co/Fj85ry9thu

[Jorge Conde @JorgeCondeBio]

@JMaraganore 🙌

[Jorge Conde @JorgeCondeBio]

@bradloncar 🙌